The collaboration will combine Sosei’s structure-based drug design capabilities with Takeda’s discovery, development and therapeutic area expertise. More: Sosei Heptares, Takeda embark on strategic R&D partnership Source: News
read moreThe 20 hospitals set to be upgraded at a cost of £850 million have been announced. More: New PM pledges £1.8bn to NHS Source: News
read moreIt’s no secret that Clovis Oncology is up against some serious marketing muscle in the PARP inhibitor arena. And investors are doubting the company’s ability to hang in there. More: Clovis investors lose faith as Rubraca struggles against Big Pharma's
read moreSince Shire Korea CEO took on the new Takeda Korea CEO job during the merger, the reorganization process has favored the Shire employees, a Takeda union has complained, in contrast to management’s recent “minimal” changes comment. More: Takeda staffers accuse
read moreFujifilm has sealed the deal. With the completion of an $890 million, all-cash exchange with Biogen, the CDMO is now in possession of a biologics production facility in Denmark with about 800 employees. More: Fujifilm pays Biogen nearly B for Denmark
read morePresident Donald Trump and Democratic presidential candidate Bernie Sanders amplified calls for drug importation this week, putting pharma on defense. And the chatter is only getting louder ahead of next year’s elections. More: Longtime pharma critic and Democratic candidate Sanders
read more© 1994 - 2026 B.M. Pharmaceuticals